⌘K

Login Start Free

Home/Filings/4/A/0000899243-22-007415

4/A//SEC Filing

Kalled Susan 4/A

Accession 0000899243-22-007415

CIK 0001738021other

View on SEC.gov Company Profile

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 5:30 PM ET

Size

5.6 KB

Accession

0000899243-22-007415

Insider Transaction Report

Form 4/AAmended

Period: 2022-02-18

Compass Therapeutics, Inc.CMPX

Chief Scientific Officer

Transactions

Award
Stock Option (Right to Buy)
2022-02-18+60,000→ 60,000 total
Exercise: $2.40Exp: 2032-02-17→ Common Stock (60,000 underlying)

Footnotes (1)

[F1]The options vest over 48 substantially equal monthly installments starting 03/17/2022.

Documents

1 file

4
doc4a.xml
FORM 4/A SUBMISSION

Issuer

Compass Therapeutics, Inc.

CIK 0001738021

Entity typeother

Related Parties

1

filerCIK 0001860504

Filing Metadata

Form type: 4/A
Filed: Feb 22, 7:00 PM ET
Accepted: Feb 23, 5:30 PM ET
Size: 5.6 KB

View on SEC.gov